Court orders destruction of Taeyeon Medical kyphoplasty product stock and manufacturing equipment.
Medtronic has announced that the High Court in Seoul, Korea has found that the balloon kyphoplasty device made by Taeyeon Medical infringes a valid Medtronic patent and has ordered destruction of Taeyeon’s stock of the infringing device and related manufacturing equipment.
“We are pleased by the High Court’s ruling,” said Alex DiNello, vice president and general manager of the Kyphon Products Division of Medtronic, which markets Kyphon Balloon Kyphoplasty for the treatment of vertebral compression fractures. “We have solid patents protecting our kyphoplasty products, and we are committed to vigorously defending our intellectual property.”
Taeyeon brands impacted by this legal decision are Typhoon and Balex. The product and manufacturing equipment destruction order was enforced on October 12, 2010 by bailiffs of the Korean court.Taeyeon is appealing the decision to the Korean Supreme Court.